Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001033094 | SCV001196401 | likely pathogenic | Multiple sulfatase deficiency | 2019-04-08 | criteria provided, single submitter | clinical testing | This variant is an in-frame deletion of the genomic region encompassing exon 2 of the SUMF1 gene. It preserves the integrity of the reading frame. This variant has not been reported in the literature in individuals with SUMF1-related conditions. This variant disrupts the p.Glu113 amino acid residue in SUMF1. Other variant(s) that disrupt this residue have been observed in individuals with SUMF1-related conditions (PMID: 28566233), suggesting that it is a clinically significant residue. As a result, variants that disrupt this residue are likely to be causative of disease. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |